Butterfly Network, Inc. develops and sells ultrasound imaging solutions, primarily targeting healthcare providers, hospitals, and physicians. Its main products include the Butterfly iQ (handheld ultrasound), Butterfly iQ+ (point-of-care device), and Butterfly Blueprint (system-wide ultrasound platform). Revenue is generated through direct sales, distributors, and eCommerce channels, with additional income from software subscriptions and educational services. Factors supporting endurance include the growing demand for portable ultrasound technology and integration into healthcare systems, while potential limitations involve competition from established imaging companies and regulatory challenges in the healthcare sector.
—
Butterfly Network, Inc. develops and sells ultrasound imaging solutions, primarily targeting healthcare providers, hospitals, and physicians. Its main products include the Butterfly iQ (handheld ultrasound), Butterfly iQ+ (point-of-care device), and Butterfly Blueprint (system-wide ultrasound platform). Revenue is generated through direct sales, distributors, and eCommerce channels, with additional income from software subscriptions and educational services. Factors supporting endurance include the growing demand for portable ultrasound technology and integration into healthcare systems, while potential limitations involve competition from established imaging companies and regulatory challenges in the healthcare sector.
—
Daily adjusted close
Butterfly Network, Inc. develops and sells ultrasound imaging solutions, primarily targeting healthcare providers, hospitals, and physicians. Its main products include the Butterfly iQ (handheld ultrasound), Butterfly iQ+ (point-of-care device), and Butterfly Blueprint (system-wide ultrasound platform). Revenue is generated through direct sales, distributors, and eCommerce channels, with additional income from software subscriptions and educational services. Factors supporting endurance include the growing demand for portable ultrasound technology and integration into healthcare systems, while potential limitations involve competition from established imaging companies and regulatory challenges in the healthcare sector.